Organoid Medicine

Organoid Medicine (Shanghai) Co., Ltd., also known as AccuOrganoid, is a leading biotechnology company specializing in organoid technology for precision medicine and drug development. Founded in 2018 and headquartered in Shanghai, the company leverages its proprietary AccuOrganoid platform to create patient-derived organoids (PDOs) that accurately mimic human organ structure and function. These models are used for high-throughput drug screening, personalized drug sensitivity testing, and disease modeling, particularly in oncology. Organoid Medicine aims to bridge the gap between preclinical research and clinical outcomes by providing more predictive human-relevant models. The company also maintains an extensive organoid biobank and collaborates with pharmaceutical companies and clinical institutions to accelerate the development of innovative therapies.